Lactobacilli to prevent traveler's diarrhea?

New England Journal of Medicine

Volumn 333, Issue 20, 1995, Pages 1360-1361

  Katelaris, Peter H ^a   Salam, Imroz ^b   Farthing, Michael J g ^b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INFECTION RESISTANCE; INFECTION RISK; LACTOBACILLUS; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRAVELLER DIARRHEA;

ACUTE DISEASE; DIARRHEA; DOUBLE-BLIND METHOD; HUMAN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; TRAVEL;

EID: 0028820143     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199511163332016     Document Type: Letter

References (4)

1. Steffen R Epidemiologic studies of travelers' diarrhea, severe gastrointestinal infections, and cholera. Rev Infect Dis 1986; 8: Suppl 2: S122-S130
2. DuPont HL, Ericsson CD Prevention and treatment of traveler's diarrhea. N Engl J Med 1993; 328: 1821-1827
3. Oksanen PJ, Salminen S, Saxelin M, Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990; 22: 53-56
4. Bernet MF, Brassart D, Neeser JR, Servin AL Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-489